Cargando…

Characterization of Clostridium difficile Strains in British Columbia, Canada: A Shift from NAP1 Majority (2008) to Novel Strain Types (2013) in One Region

Background. Clostridium difficile is a major cause of gastrointestinal illness. Epidemic NAP1 strains contain toxins A and B, a deletion in repressor tcdC, and a binary toxin. Objectives. To determine the molecular epidemiology of C. difficile in British Columbia and compare between two time points...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jassem, Agatha N., Prystajecky, Natalie, Marra, Fawziah, Kibsey, Pamela, Tan, Kennard, Umlandt, Patricia, Janz, Loretta, Champagne, Sylvie, Gamage, Bruce, Golding, George R., Mulvey, Michael R., Henry, Bonnie, Hoang, Linda M. N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904575/ https://www.ncbi.nlm.nih.gov/pubmed/27366181 http://dx.doi.org/10.1155/2016/8207418

Ejemplares similares

Retrospective Cohort Analysis of Outpatient Antibiotic Use for Clostridioides difficile-Indicated Agents in British Columbia, from 2000 to 2018
por: Saatchi, Ariana, et al.
Publicado: (2023)

Proteomic Analysis of a NAP1 Clostridium difficile Clinical Isolate Resistant to Metronidazole
por: Chong, Patrick M., et al.
Publicado: (2014)

Increasing incidence associated with herpes zoster infection in British Columbia, Canada
por: Marra, Fawziah, et al.
Publicado: (2016)

1118. Trends of Paediatric Prescribing for Common Infections in British Columbia
por: Saatchi, Ariana, et al.
Publicado: (2019)

Clostridium difficile Enteritis With NAP7/078 Toxigenic Strain
por: Zewude, Rahel T, et al.
Publicado: (2023)

Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada
por: Fibke, Chad D., et al.
Publicado: (2022)

2705. Serotype Replacement Following Childhood Pneumococcal Conjugate Vaccination Programs in British Columbia, Canada
por: Vadlamudi, Nirma K, et al.
Publicado: (2019)

1117. A Retrospective Analysis of Paediatric Prescribing in British Columbia from 2013 to 2016
por: Saatchi, Ariana, et al.
Publicado: (2019)

2701. The Impact of Infant 13-valent Conjugate Pneumococcal Vaccination Program on Invasive Pneumococcal Disease in Children in British Columbia, Canada
por: Vadlamudi, Nirma K, et al.
Publicado: (2019)

Effectiveness of neuraminidase inhibitors in preventing hospitalization during the H1N1 influenza pandemic in British Columbia, Canada
por: Marra, Fawziah, et al.
Publicado: (2014)

Risk Factors for BI/NAP1/027 Clostridioides difficile Infections and Clinical Outcomes Compared With Non-NAP1 Strains
por: Mani, Nandita S, et al.
Publicado: (2019)

Novel Avian Influenza H7N3 Strain Outbreak, British Columbia
por: Hirst, Martin, et al.
Publicado: (2004)

2706. Indirect Effects of Infant 13-valent Conjugate Pneumococcal Vaccination Program on Invasive Pneumococcal Disease in Adults in British Columbia, Canada
por: Vadlamudi, Nirma K, et al.
Publicado: (2019)

Prevalence of Hypervirulent BI/NAP1/027 Clostridium difficile Strains in Cali-Colombia
por: Rosso, Fernando, et al.
Publicado: (2017)

Quantifying the Gap between Expected and Actual Rates of Antibiotic Prescribing in British Columbia, Canada
por: Saatchi, Ariana, et al.
Publicado: (2021)

214. Antibiotic Use for Common Infections in British Columbia: A Review of Outpatient Prescribing from 2000 - 2018
por: Saatchi, Ariana, et al.
Publicado: (2020)

Characterization of Legionella Species from Watersheds in British Columbia, Canada
por: Peabody, Michael A., et al.
Publicado: (2017)

Clostridium difficile outbreak caused by NAP1/BI/027 strain and non-027 strains in a Mexican hospital
por: Morfin-Otero, Rayo, et al.
Publicado: (2015)

221. Comparison of dental antibiotic prescribing between Australia, England, the United States and British Columbia in 2017
por: Teoh, Leanne, et al.
Publicado: (2020)

Outpatient antibiotic use in British Columbia, Canada: reviewing major trends since 2000
por: Saatchi, Ariana, et al.
Publicado: (2021)

Community Antibiotic Use at the Population Level During the SARS-CoV-2 Pandemic in British Columbia, Canada
por: Mamun, Abdullah A, et al.
Publicado: (2021)

The Hypervirulent Strain of Clostridium Difficile: NAP1/B1/027 - A Brief Overview
por: Fatima, Rawish, et al.
Publicado: (2019)

Incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate pneumococcal vaccine in British Columbia: A retrospective cohort study
por: Vadlamudi, Nirma Khatri, et al.
Publicado: (2020)

Looking Upstream: Findings from Focus Groups on Public Perceptions of Source Water Quality in British Columbia, Canada
por: Henrich, Natalie, et al.
Publicado: (2015)

Comparative biofilm-forming ability between Clostridioides difficile strains isolated in Latin America and the epidemic NAP1/027 strain
por: Morais, Maria Luana Gaudencio dos Santos, et al.
Publicado: (2022)

Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada
por: Tanunliong, Guadalein, et al.
Publicado: (2022)

The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada
por: Nikiforuk, Aidan M., et al.
Publicado: (2021)

Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January–April 2021
por: Hogan, Catherine A., et al.
Publicado: (2021)

Population SARS-CoV-2 Seroprevalence Using Antenatal Serum Samples in British Columbia, Canada
por: McClymont, Elisabeth, et al.
Publicado: (2021)

748. The Changing Epidemiology of Clostridioides difficile Infection and the NAP1/027 Strain in Two Quebec Hospitals
por: Couture, Sandrine, et al.
Publicado: (2021)

Assessing oligonucleotide designs from early lab developed PCR diagnostic tests for SARS-CoV-2 using the PCR_strainer pipeline
por: Kuchinski, Kevin S., et al.
Publicado: (2020)

Highlight: British Columbia
Publicado: (2005)

Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008–2019
por: Pearce, Margo E., et al.
Publicado: (2020)

479. Trends in C. difficile Incidence, Mortality, and NAP1/027 Strain in the Population of Monroe County, New York
por: Hatwar, Trupti, et al.
Publicado: (2018)

Predicting tuberculosis risk in the foreign-born population of British Columbia, Canada: study protocol for a retrospective population-based cohort study
por: Ronald, Lisa A, et al.
Publicado: (2016)

Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2021)

Hospital for the Insane in British Columbia
Publicado: (1904)

Mental Nursing in British Columbia
por: Kirkpatrick, W. J. A.
Publicado: (1965)

The geography of overdose in British Columbia.
por: Slaunwhite, Amanda, et al.
Publicado: (2022)

Medical Persecution in British Columbia
por: Hall, John
Publicado: (1891)

Cannot write session to /tmp/vufind_sessions/sess_ku6ku8buai09b7btpe2ktnpsme